Tumor-associated macrophages in the cutaneous SCC microenvironment are heterogeneously activated

Julia S. Pettersen, Judilyn Fuentes-Duculan, Mayte Suárez-Farĩas, Katherine C. Pierson, Alexander Pitts-Kiefer, Linda Fan, Daniel A. Belkin, Claire Q F Wang, Shivaprasad Bhuvanendran, Leanne M. Johnson-Huang, Mark J. Bluth, James G. Krueger, Michelle A. Lowes, John A. Carucci

Research output: Contribution to journalArticle

87 Citations (Scopus)

Abstract

Tumor-associated macrophages (TAMs) may have an important role in tumor immunity. We studied the activation state of TAMs in cutaneous SCC, the second most common human cancer. CD163+ was identified as a more abundant, sensitive, and accurate marker of TAMs when compared with CD68. CD163 TAMs produced protumoral factors, matrix metalloproteinases 9 and 11 (MMP9 and MMP11), at the gene and protein levels. Gene set enrichment analysis (GSEA) was used to evaluate M1 and M2 macrophage gene sets in the SCC genes and to identify candidate genes in order to phenotypically characterize TAMs. There was coexpression of CD163 and alternatively activated M2 markers, CD209 and CCL18 (chemokine (C-C motif) ligand 18). There was enrichment for classically activated M1 genes in SCC, which was confirmed in situ by colocalization of CD163 and phosphorylated STAT1 (signal transducer and activator of transcription 1), IL-23p19, IL-12/IL-23p40, and CD127. Also, a subset of TAMs in SCC was bi-activated as CD163 cells expressed markers for both M1 and M2, shown by triple-label immunofluorescence. These data support heterogeneous activation states of TAMs in SCC, and suggest that a dynamic model of macrophage activation would be more useful to characterize TAMs.

Original languageEnglish (US)
Pages (from-to)1322-1330
Number of pages9
JournalJournal of Investigative Dermatology
Volume131
Issue number6
DOIs
StatePublished - Jun 2011
Externally publishedYes

Fingerprint

Macrophages
Tumors
Skin
Neoplasms
Genes
Chemical activation
Interleukin-23 Subunit p19
Matrix Metalloproteinase 11
STAT1 Transcription Factor
CC Chemokines
Gene Order
Macrophage Activation
Matrix Metalloproteinase 9
Interleukin-12
Tumor Biomarkers
Fluorescent Antibody Technique
Immunity
Labels
Dynamic models
Ligands

ASJC Scopus subject areas

  • Dermatology
  • Biochemistry
  • Cell Biology
  • Molecular Biology

Cite this

Pettersen, J. S., Fuentes-Duculan, J., Suárez-Farĩas, M., Pierson, K. C., Pitts-Kiefer, A., Fan, L., ... Carucci, J. A. (2011). Tumor-associated macrophages in the cutaneous SCC microenvironment are heterogeneously activated. Journal of Investigative Dermatology, 131(6), 1322-1330. https://doi.org/10.1038/jid.2011.9

Tumor-associated macrophages in the cutaneous SCC microenvironment are heterogeneously activated. / Pettersen, Julia S.; Fuentes-Duculan, Judilyn; Suárez-Farĩas, Mayte; Pierson, Katherine C.; Pitts-Kiefer, Alexander; Fan, Linda; Belkin, Daniel A.; Wang, Claire Q F; Bhuvanendran, Shivaprasad; Johnson-Huang, Leanne M.; Bluth, Mark J.; Krueger, James G.; Lowes, Michelle A.; Carucci, John A.

In: Journal of Investigative Dermatology, Vol. 131, No. 6, 06.2011, p. 1322-1330.

Research output: Contribution to journalArticle

Pettersen, JS, Fuentes-Duculan, J, Suárez-Farĩas, M, Pierson, KC, Pitts-Kiefer, A, Fan, L, Belkin, DA, Wang, CQF, Bhuvanendran, S, Johnson-Huang, LM, Bluth, MJ, Krueger, JG, Lowes, MA & Carucci, JA 2011, 'Tumor-associated macrophages in the cutaneous SCC microenvironment are heterogeneously activated', Journal of Investigative Dermatology, vol. 131, no. 6, pp. 1322-1330. https://doi.org/10.1038/jid.2011.9
Pettersen JS, Fuentes-Duculan J, Suárez-Farĩas M, Pierson KC, Pitts-Kiefer A, Fan L et al. Tumor-associated macrophages in the cutaneous SCC microenvironment are heterogeneously activated. Journal of Investigative Dermatology. 2011 Jun;131(6):1322-1330. https://doi.org/10.1038/jid.2011.9
Pettersen, Julia S. ; Fuentes-Duculan, Judilyn ; Suárez-Farĩas, Mayte ; Pierson, Katherine C. ; Pitts-Kiefer, Alexander ; Fan, Linda ; Belkin, Daniel A. ; Wang, Claire Q F ; Bhuvanendran, Shivaprasad ; Johnson-Huang, Leanne M. ; Bluth, Mark J. ; Krueger, James G. ; Lowes, Michelle A. ; Carucci, John A. / Tumor-associated macrophages in the cutaneous SCC microenvironment are heterogeneously activated. In: Journal of Investigative Dermatology. 2011 ; Vol. 131, No. 6. pp. 1322-1330.
@article{edd86d7dbd414ada8b5b83a6402322a6,
title = "Tumor-associated macrophages in the cutaneous SCC microenvironment are heterogeneously activated",
abstract = "Tumor-associated macrophages (TAMs) may have an important role in tumor immunity. We studied the activation state of TAMs in cutaneous SCC, the second most common human cancer. CD163+ was identified as a more abundant, sensitive, and accurate marker of TAMs when compared with CD68. CD163 TAMs produced protumoral factors, matrix metalloproteinases 9 and 11 (MMP9 and MMP11), at the gene and protein levels. Gene set enrichment analysis (GSEA) was used to evaluate M1 and M2 macrophage gene sets in the SCC genes and to identify candidate genes in order to phenotypically characterize TAMs. There was coexpression of CD163 and alternatively activated M2 markers, CD209 and CCL18 (chemokine (C-C motif) ligand 18). There was enrichment for classically activated M1 genes in SCC, which was confirmed in situ by colocalization of CD163 and phosphorylated STAT1 (signal transducer and activator of transcription 1), IL-23p19, IL-12/IL-23p40, and CD127. Also, a subset of TAMs in SCC was bi-activated as CD163 cells expressed markers for both M1 and M2, shown by triple-label immunofluorescence. These data support heterogeneous activation states of TAMs in SCC, and suggest that a dynamic model of macrophage activation would be more useful to characterize TAMs.",
author = "Pettersen, {Julia S.} and Judilyn Fuentes-Duculan and Mayte Su{\'a}rez-Farĩas and Pierson, {Katherine C.} and Alexander Pitts-Kiefer and Linda Fan and Belkin, {Daniel A.} and Wang, {Claire Q F} and Shivaprasad Bhuvanendran and Johnson-Huang, {Leanne M.} and Bluth, {Mark J.} and Krueger, {James G.} and Lowes, {Michelle A.} and Carucci, {John A.}",
year = "2011",
month = "6",
doi = "10.1038/jid.2011.9",
language = "English (US)",
volume = "131",
pages = "1322--1330",
journal = "Journal of Investigative Dermatology",
issn = "0022-202X",
publisher = "Nature Publishing Group",
number = "6",

}

TY - JOUR

T1 - Tumor-associated macrophages in the cutaneous SCC microenvironment are heterogeneously activated

AU - Pettersen, Julia S.

AU - Fuentes-Duculan, Judilyn

AU - Suárez-Farĩas, Mayte

AU - Pierson, Katherine C.

AU - Pitts-Kiefer, Alexander

AU - Fan, Linda

AU - Belkin, Daniel A.

AU - Wang, Claire Q F

AU - Bhuvanendran, Shivaprasad

AU - Johnson-Huang, Leanne M.

AU - Bluth, Mark J.

AU - Krueger, James G.

AU - Lowes, Michelle A.

AU - Carucci, John A.

PY - 2011/6

Y1 - 2011/6

N2 - Tumor-associated macrophages (TAMs) may have an important role in tumor immunity. We studied the activation state of TAMs in cutaneous SCC, the second most common human cancer. CD163+ was identified as a more abundant, sensitive, and accurate marker of TAMs when compared with CD68. CD163 TAMs produced protumoral factors, matrix metalloproteinases 9 and 11 (MMP9 and MMP11), at the gene and protein levels. Gene set enrichment analysis (GSEA) was used to evaluate M1 and M2 macrophage gene sets in the SCC genes and to identify candidate genes in order to phenotypically characterize TAMs. There was coexpression of CD163 and alternatively activated M2 markers, CD209 and CCL18 (chemokine (C-C motif) ligand 18). There was enrichment for classically activated M1 genes in SCC, which was confirmed in situ by colocalization of CD163 and phosphorylated STAT1 (signal transducer and activator of transcription 1), IL-23p19, IL-12/IL-23p40, and CD127. Also, a subset of TAMs in SCC was bi-activated as CD163 cells expressed markers for both M1 and M2, shown by triple-label immunofluorescence. These data support heterogeneous activation states of TAMs in SCC, and suggest that a dynamic model of macrophage activation would be more useful to characterize TAMs.

AB - Tumor-associated macrophages (TAMs) may have an important role in tumor immunity. We studied the activation state of TAMs in cutaneous SCC, the second most common human cancer. CD163+ was identified as a more abundant, sensitive, and accurate marker of TAMs when compared with CD68. CD163 TAMs produced protumoral factors, matrix metalloproteinases 9 and 11 (MMP9 and MMP11), at the gene and protein levels. Gene set enrichment analysis (GSEA) was used to evaluate M1 and M2 macrophage gene sets in the SCC genes and to identify candidate genes in order to phenotypically characterize TAMs. There was coexpression of CD163 and alternatively activated M2 markers, CD209 and CCL18 (chemokine (C-C motif) ligand 18). There was enrichment for classically activated M1 genes in SCC, which was confirmed in situ by colocalization of CD163 and phosphorylated STAT1 (signal transducer and activator of transcription 1), IL-23p19, IL-12/IL-23p40, and CD127. Also, a subset of TAMs in SCC was bi-activated as CD163 cells expressed markers for both M1 and M2, shown by triple-label immunofluorescence. These data support heterogeneous activation states of TAMs in SCC, and suggest that a dynamic model of macrophage activation would be more useful to characterize TAMs.

UR - http://www.scopus.com/inward/record.url?scp=79955983027&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955983027&partnerID=8YFLogxK

U2 - 10.1038/jid.2011.9

DO - 10.1038/jid.2011.9

M3 - Article

VL - 131

SP - 1322

EP - 1330

JO - Journal of Investigative Dermatology

JF - Journal of Investigative Dermatology

SN - 0022-202X

IS - 6

ER -